comparemela.com
  1. Home
  2. Live Updates
  3. Bradleyw Christensen - Breaking News

Latest Breaking News On - Bradleyw christensen - Page 1 : comparemela.com

Dr Christensen on the Influence of Patient Selection for BCL-2 Inhibitor Treatment in AML

Bradley W. Christensen, MD, discusses the process of patient selection for BCL-2 induction therapy in patients with acute myeloid leukemia in accordance with their individual disease characteristics.

United statesBradleyw christensenBaylor charlesa sammons cancer centerTexas oncology baylor charlesCancer centerTexas oncology baylor charlesa sammons cancer centerVialea trialPatients with acute myeloid leukemiaBcl 2 inhibitorsTp53 mutationsInduction chemotherapyIdh1 2 mutations

Dr Christensen on Azacitidine Plus Venetoclax in AML

Bradley W. Christensen, MD, discusses findings from the phase 3 VIALE-A trial in patients with acute myeloid leukemia.

United statesBradleyw christensenBaylor charlesa sammons cancer centerTexas oncology baylor charlesCancer centerTexas oncology baylor charlesa sammons cancer centerVialea trialPatients with acute myeloid leukemia

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.